• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

GENVEC, INC.

NASDAQ:GNVC

$2.50 -$0.01 (-0.40%)

Quote as of

Jump to this page for:

Related Resources

GenVec Reports Inducement Award

5/25/2012 by PR Newswire

GenVec names Cynthia Collins new CEO

5/21/2012 by Washington Business Journal - Washington DC

GenVec Inc. Appoints as President and CEO

5/21/2012 by BioSpace

GenVec (GNVC) CEO Fischer to Step Down; Successor Named

5/21/2012 by StreetInsider.com

GenVec appoints Cynthia Collins as CEO and President

5/21/2012 by Theflyonthewall.com

GenVec Appoints Cynthia Collins as President and CEO

5/21/2012 by PR Newswire

GenVec revenue falls, loss widens

5/10/2012 by Washington Business Journal - Washington DC

GenVec reports Q1 EPS (25c), one estimate (13c)

5/10/2012 by Theflyonthewall.com

GenVec Reports First Quarter 2012 Financial Results

5/10/2012 by PR Newswire

GenVec Awarded Grant For RSV Vaccine Program

5/3/2012 by StockWatch

GenVec (GNVC) Gets $590K SBIR Grant from NIAID of NIH

5/3/2012 by StreetInsider.com

GenVec awarded grant for RSV vacinne program

5/3/2012 by Theflyonthewall.com

GenVec Announces Research on Improved Vaccine Vectors

4/6/2012 by Genetic Engineering News

GenVec Announces Research on Improved Vaccine Vectors

4/6/2012 by PR Newswire

Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position

4/3/2012 by StockWatch

Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position

4/3/2012 by Business Wire

GenVec Awarded Grant for Antigen Discovery Project

3/26/2012 by PR Newswire

Promising data presented on GenVec RSV program

3/23/2012 by Theflyonthewall.com

Promising Data Presented On GenVec RSV Program

3/23/2012 by PR Newswire

GenVec, Inc. New (GNVC) Posts Q4 Loss of 19c/Share, Misses Views

3/15/2012 by StreetInsider.com

GenVec Reports Fourth Quarter and 2011 Year-End Financial Results

3/15/2012 by StockWatch

GenVec reports Q4 EPS (19c), one estimate (14c)

3/15/2012 by Theflyonthewall.com

GenVec expects FY12 cash burn to average $2M per quarter

3/15/2012 by Theflyonthewall.com

GenVec Reports Fourth Quarter and 2011 Year-End Financial Results

3/15/2012 by PR Newswire

Companies reporting Before the Market Open on Thursday, March 15

3/14/2012 by Theflyonthewall.com

Brower Piven, the Only Firm to Have Filed a Class Action Lawsuit Against GenVec, Inc. for Securities Violations Between March 12, 2009 and March 30, 2010, Reminds Investors of the Upcoming Deadline to Move for Appointment as Lead Plaintiff -- GNVC

3/8/2012 by GlobeNewswire

GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012

3/7/2012 by PR Newswire

GenVec to Present at the ROTH 24th Annual Growth Stock Conference

3/6/2012 by PR Newswire

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position

2/8/2012 by StockWatch

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in GenVec, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position

2/8/2012 by Business Wire

Robbins Umeda LLP Announces the Filing of a Class Action Suit Against GenVec, Inc.

2/7/2012 by StockWatch

Robbins Umeda LLP Announces the Filing of a Class Action Suit Against GenVec, Inc.

2/7/2012 by Business Wire

GenVec to Present at the 14th Annual BIO CEO & Investor Conference

2/7/2012 by PR Newswire

Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.

2/6/2012 by StockWatch

Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.

2/6/2012 by PR Newswire

Brower Piven Files Class Action Suit Against GenVec, Inc.

2/3/2012 by StockWatch

Brower Piven Files Class Action Suit Against GenVec, Inc.

2/3/2012 by Marketwire

GenVec Extends Research Collaboration with Global Pharmaceutical Company

1/27/2012 by Pharmaceutical and Medical Packaging News

GenVec rises 6.6%

1/27/2012 by Theflyonthewall.com

GenVec Extends Research Collaboration with Global Pharmaceutical Company

1/27/2012 by PR Newswire
See More Articles...